CTT Pharmaceutical Holdings Inc
CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment. It focuses on fast dissolving drug delivery systems. The company's technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.… Read more
CTT Pharmaceutical Holdings Inc (CTTH) - Total Liabilities
Latest total liabilities as of June 2025: $20.03K USD
Based on the latest financial reports, CTT Pharmaceutical Holdings Inc (CTTH) has total liabilities worth $20.03K USD as of June 2025.
Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities.
CTT Pharmaceutical Holdings Inc - Total Liabilities Trend (1999–2024)
This chart illustrates how CTT Pharmaceutical Holdings Inc's total liabilities have evolved over time, based on quarterly financial data. Explore and compare other companies by total liabilities.
CTT Pharmaceutical Holdings Inc Competitors by Total Liabilities
The table below lists competitors of CTT Pharmaceutical Holdings Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Haloni Jane
JK:HALO
|
Indonesia | Rp69.66 Billion |
|
Solvbl Solutions Inc
PINK:SOLBF
|
USA | $3.30 Million |
|
Indigo Exploration Inc.
PINK:IXIXF
|
USA | $440.76K |
|
INSMED
BE:IM8N
|
Germany | €1.57 Billion |
|
ATI Physical Therapy Inc
NYSE:ATIP
|
USA | $1.13 Billion |
|
EQUIFAX INC - Dusseldorf Stock Exchang
DU:EFX
|
Germany | €7.30 Billion |
|
MetaVia Inc.
NASDAQ:MTVA
|
USA | $8.43 Million |
Liability Composition Analysis (1999–2024)
This chart breaks down CTT Pharmaceutical Holdings Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 1.62 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.24 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.20 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how CTT Pharmaceutical Holdings Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for CTT Pharmaceutical Holdings Inc (1999–2024)
The table below shows the annual total liabilities of CTT Pharmaceutical Holdings Inc from 1999 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | $40.86K | +111.80% |
| 2023-12-31 | $19.29K | +318.10% |
| 2022-12-31 | $4.61K | -95.50% |
| 2021-12-31 | $102.42K | -84.54% |
| 2020-12-31 | $662.60K | +47.12% |
| 2019-12-31 | $450.38K | +60.08% |
| 2018-12-31 | $281.35K | +1.89% |
| 2017-12-31 | $276.12K | +34.37% |
| 2016-12-31 | $205.49K | -33.39% |
| 2015-12-31 | $308.48K | -71.32% |
| 2014-12-31 | $1.08 Million | +3301.66% |
| 2014-02-28 | $31.62K | -87.32% |
| 2013-12-31 | $249.38K | -57.69% |
| 2012-12-31 | $589.41K | -84.18% |
| 2011-12-31 | $3.73 Million | +195.54% |
| 2010-12-31 | $1.26 Million | -45.74% |
| 2009-12-31 | $2.32 Million | +66.23% |
| 2008-12-31 | $1.40 Million | +7.47% |
| 2007-12-31 | $1.30 Million | +35.15% |
| 2006-12-31 | $962.58K | -53.81% |
| 2005-12-31 | $2.08 Million | +730.21% |
| 2004-12-31 | $251.01K | -92.45% |
| 2003-12-31 | $3.32 Million | +240.59% |
| 2002-12-31 | $976.10K | +5436.91% |
| 2001-12-31 | $17.63K | -79.96% |
| 2000-12-31 | $87.95K | +0.57% |
| 1999-12-31 | $87.45K | -- |